GE Healthcare partners to create manufacturing suite for gene therapies

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Bulat Silvia)
(Image: Getty/Bulat Silvia)

Related tags: Ge healthcare, FlexFactory, Germfree, Gene therapy

GE Healthcare teams up with Germfree to create a fully integrated, expandable manufacturing solution that is geared towards the development of ‘emerging biotherapeutics’.

GE Healthcare will provide its proprietary design work for the facility, alongside its FlexFactory single-use biomanufacturing platform, while Germfree will provide process-ready cleanroom facilities to round out the offering.

A spokesperson for GE Healthcare told us that the solution will include a biosafety level 2 (BSL-2) environment design, which is suitable to be paired with the company’s biomanufacturing platform for gene therapies.

Together, a platform will be developed that will increase ‘capacity and capability’ in the gene therapy market, the companies stated.

A spokesperson for GE Healthcare told us that the technology can be scaled up to meet customers’ needs: “This good manufacturing practice compliant solution will allow manufacturers of biotherapeutics to expand their capacity (scale-out/scale up) through clinical and commercial manufacturing. The modular design will allow customers to expand by adding new modules as needed.”

The development comes as larger companies in the gene therapy have taken the step to build out their own gene therapy manufacturing capabilities.

Iovance recently increased its clinical and commercial capabilities​ with a $75m (€67.3m) investment and Pfizer recently chose to do the same ahead of the start of a Phase III clinical trial​ for its Duchenne muscular dystrophy gene therapy candidate.

GE Healthcare and Germfree’s manufacturing offering comes amid a wider regenerative medicine market that is predicted to grow at compound annual growth rate (CAGR) of 23.8%​.

The spokesperson told us the technology would be available by the end of October.

Related news

Show more

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Related suppliers

Follow us

Products

View more

Webinars